Inflammation
- F1337 Anti-PDCD1/PD-1/CD279 Antibody (Toripalimab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Toripalimab)
- F1338 Anti-PDCD1/PD-1/CD279 Antibody (Zimberelimab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Zimberelimab)
- F1339 Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Camrelizumab)
- F1340 Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Nivolumab)
- F1341 Anti-PDCD1/PD-1/CD279 Antibody (Pembrolizumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Pembrolizumab)
- F1342 Anti-PDCD1/PD-1/CD279 Antibody (Serplulimab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Serplulimab)
- F1343 Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab)Summary: Anti-PDCD1/PD-1/CD279 Antibody (Spartalizumab)
- F1344 Anti-TLR2/CD282 Antibody (Tomaralimab)Summary: Anti-TLR2/CD282 Antibody (Tomaralimab)
- F1345 Anti-CD19 Antibody (Inebilizumab)Summary: Anti-CD19 Antibody (Inebilizumab)
- F1346 Anti-CD6 Antibody (Itolizumab)Summary: Anti-CD6 Antibody (Itolizumab)